Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Accenture
Boehringer Ingelheim
Healthtrust
Covington
Novartis
Fuji
Mallinckrodt
Citi
AstraZeneca

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,106,865

« Back to Dashboard

Summary for Patent: 6,106,865
Title: Pharmaceutical excipient having improved compressibility
Abstract:A composition, comprising (a) microcrystalline cellulose; and (b) a compressibility augmenting agent which (i) physically restricts the proximity of the interface between adjacent cellulose surfaces; or (ii) inhibits interactions between adjacent cellulose surfaces; or (iii) accomplishes both (i) and (ii) above, is disclosed. The composition is in the form of agglomerated particles of microcrystalline cellulose and the compressibility augmenting agent in intimate association with each other.
Inventor(s): Staniforth; John N. (Bath, GB), Hunter; Edward A. (Glenham, NY), Sherwood; Bob E. (Amenia, NY)
Assignee: Edward Mendell Co., Inc. (Patterson, NY)
Application Number:09/037,841
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use; Formulation;

Drugs Protected by US Patent 6,106,865

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,106,865

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 239450 ➤ Subscribe
Austria 441403 ➤ Subscribe
Austria 445391 ➤ Subscribe
Australia 4759896 ➤ Subscribe
Australia 5019996 ➤ Subscribe
Australia 5830399 ➤ Subscribe
Australia 698667 ➤ Subscribe
Australia 708346 ➤ Subscribe
Australia 737464 ➤ Subscribe
Brazil 9605245 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Deloitte
Chinese Patent Office
Harvard Business School
Daiichi Sankyo
Novartis
Farmers Insurance
Healthtrust
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot